medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2009, Number 4

<< Back Next >>

Rev Mex Patol Clin Med Lab 2009; 56 (4)

Proposal of a new model of cord blood bank for Latin America

Calderón GED

Language: Spanish
References: 8
Page: 271-277
PDF size: 64.75 Kb.


ABSTRACT

The cord blood bank (CBB) is a therapeutic tool that complements the needs of clinical programs in bone marrow transplantation and seeks the collection of hematopoietic progenitor cells classified by HLA histocompatibility antigens, for the cure of certain diseases: hematologic, oncologic, immune deficiencies, inborn errors of metabolism and hemoglobinopathies among others. The economic situation of the Latin American countries requires to establish a model of cord blood bank that can be sustainable long term. The concrete proposal is to create a mixed cord blood bank: a cord blood bank dedicated to collecting, processing, study, storage, sorting and release of hematopoietic progenitor units for use in unrelated transplants and/or for family use, that conforms an inventory from 3,000 to 4,000 units of high quality, guaranteed for transplantation. This proposal aims is to form a cord blood bank that meets all the requirements that dictate NETCORD-FACT standards and be accredited by international agencies.


REFERENCES

  1. Barker JN. Umbilical Cord Blood (UCB) Transplantation: An alternative to the use of unrelated volunteer donors? Hematology Am Soc Hematol Educ Program 2007; 55-61.

  2. Estándares Internacionales de NETCORD. Norma internacional para la extracción, el procesamiento, el análisis, la conservación en bancos, la selección y la expedición de sangre de cordón umbilical. 4a ed. 2009.

  3. Gluckman E, Rocha V. Cord blood transplantation: state of the art. Haematologica 2009; 94: 451-454.

  4. Gluckman E, Rocha V. Donor selection for unrelated cord blood transplants. Curr Opin Immunol 2008; 18: 565-70.

  5. Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM. Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. Med Decis Making 2008; 28: 243-253.

  6. McCullough J, McKenna D, Kadidlo D, Schierman T, Wagner. Issues in the quality of umbilical cord blood stem cells for transplantation. J Transfusion 2005; 45: 832-41.

  7. Wall DA. Issues in the quality of umbilical cord blood stem cells for transplantation: Challenges in cord blood banking quality management. Transfusion 2005; 45: 826-828.

  8. WMDA Annual Report 2008, 10th ed.




2020     |     www.medigraphic.com